Doctor in Biology with more than 20 years of experience in drug discovery research in big pharma. Initially involved in High Throughput Screening for a wide range of target classes and therapeutic areas at SmithKline Beecham, he became a pioneer in application of cutting-edge screening technologies. Later, he held managerial positions at GlaxoSmithKline in Spain, first as Head of Biological Reagents and Assay Development with deep involvement in Open Innovation and finally as Head of External Projects, where his department was responsible for evaluation and testing of therapeutic hypotheses from academics and biotech start-ups and coordination of drug discovery projects.
This website uses cookies so that we can offer you the best possible user experience. The cookie information is stored in your browser and performs functions such as recognizing you when you return to our website or helping our team to understand which sections of the website you find most interesting and useful.